# Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy Children

> **NCT00192322** · PHASE2 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 173 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** CAIV-T 10^7
- **BIOLOGICAL:** CAIVT 10^5
- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** TIV

## Key facts

- **NCT ID:** NCT00192322
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-09
- **Primary completion:** 2001-12
- **Final completion:** 2001-12
- **Target enrollment:** 173 (ACTUAL)
- **Last updated:** 2012-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00192322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00192322, "Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy Children". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00192322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*